Pharmaceutical Mutual funds are funds which primarily invest in pharmaceutical stocks in India.
Since these mutual funds invest money in a single theme/sector, they are categorized as High Risk equity investments.
| Mutual Fund Scheme | NAV | Month | 3 Month | 6 Month | Year | 2 Year | 3 Year | As on (yy-mm-dd) |
|---|---|---|---|---|---|---|---|---|
| Reliance Pharma Fund - Direct Plan Growth Plan - Growth Option | 136.5 | 3.70% | 0.68% | -0.50% | -5.61% | -2.07% | 36.25% | 2017-07-27 |
| UTI Pharma & Healthcare Fund-Growth Option- Direct | 90.3 | 4.86% | 0.12% | 0.71% | -6.20% | -5.58% | 26.24% | 2017-07-27 |
| UTI Pharma & Healthcare Fund-Income Option-Direct | 69.8 | 4.85% | 0.13% | 0.72% | -6.20% | -5.58% | 26.24% | 2017-07-27 |
| Reliance Pharma Fund-Growth Plan-Growth Option | 131.6 | 3.62% | 0.47% | -0.91% | -6.41% | -3.82% | 32.85% | 2017-07-27 |
| UTI Pharma & Healthcare Fund-Income Option | 67.1 | 4.78% | -0.09% | 0.28% | -6.99% | -7.28% | 22.92% | 2017-07-27 |
| UTI Pharma & Healthcare Fund-Growth Option | 86.8 | 4.78% | -0.09% | 0.29% | -6.99% | -7.28% | 22.90% | 2017-07-27 |
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | 9.2 | 4.21% | -3.07% | 3.27% | -8.50% | NA | NA | 2017-07-27 |
| SBI PHARMA - DIRECT PLAN -GROWTH | 134.6 | 4.05% | -2.29% | -2.45% | -9.95% | -6.58% | 38.38% | 2017-07-27 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 8.9 | 4.09% | -3.36% | 2.53% | -10.09% | NA | NA | 2017-07-27 |
| SBI PHARMA - REGULAR PLAN -GROWTH | 128.2 | 3.96% | -2.57% | -3.00% | -11.00% | -8.86% | 33.41% | 2017-07-27 |